Human regulatory T cells (Treg) are important in immune regulation, but can also show plasticity in specific settings. CD161 is a lectin-like receptor and its expression identifies an effector-like Treg population. Here, we determined how CD161
Human regulatory T cells (Treg) are important in immune regulation, but can also show plasticity in specific settings. CD161 is a lectin-like receptor and its expression identifies an effector-like Treg population. Here, we determined how CD161
+ Treg relate to CD161 + conventional T cells (Tconv). Transcriptional profiling identified a shared transcriptional signature between CD161 + Tconv and CD161 + Treg, which is associated with T helper (Th)1 and Th17 cells, and tissue homing, including high expression of gut-homing receptors. Upon retinoic acid (RA) exposure, CD161
+ T cells were more enriched for CCR9 + and integrin α4 + β7 + cells than CD161 − T cells. In addition, CD161 + Tconv and CD161
+
Treg were enriched at the inflamed site in autoimmune arthritis, and both CD161 + and CD161 − Treg from the inflamed site were suppressive in vitro. CD161 + T cells from the site of autoimmune arthritis showed a diminished gut-homing phenotype and blunted response to RA suggesting prior imprinting by RA in the gut or at peripheral sites rather than during synovial inflammation. TCRβ repertoires of CD161 + and CD161 − Tconv and Treg from blood showed limited overlap whereas there was clear overlap between CD161 + and CD161 − Tconv, and CD161 + and CD161 − Treg from the inflamed site suggesting that the inflamed environment may alter CD161 levels, potentially contributing to disease pathogenesis.
Keywords: cD161, conventional T cells (Tconv), regulatory T cells (Treg), transcriptome, juvenile idiopathic arthritis (Jia), tissue homing, T cell receptor (Tcr), retinoic acid inTrODUcTiOn Human regulatory T cells (Treg) expressing high levels of CD25 (1), low levels of CD127 (2, 3) , and the master transcription factor Foxp3 (4-6) are key to immune regulation. The importance of Treg is clearly illustrated by the onset of severe multi-organ autoimmune diseases in absence of functional Treg (7, 8) . Treg are generally considered to lack the ability to produce pro-inflammatory cytokines (6) . However, recent ex vivo and in vitro studies have demonstrated that a proportion of Treg from healthy individuals is able to produce pro-inflammatory cytokines associated with T helper (Th) lineages such as interferon (IFN)-γ and interleukin (IL)-17 (9) (10) (11) (12) (13) (14) (15) (19) or psoriasis (20) , and IFNγ-and IL-17-producing Treg in patients with autoimmune hepatitis (21) compared to healthy individuals. This suggests that at sites of inflammation, cytokineproducing Treg might actively promote inflammation instead of dampening it.
These effector-like characteristics of Treg raise questions about the role of these cells in health and disease. We have recently identified CD161 as a marker to identify a Treg population capable of producing pro-inflammatory cytokines. CD161
+ Treg are suppressive in in vitro suppression assays and have a predominantly demethylated Treg-specific demethylated region (TSDR) (14) . CD161, the human ortholog of murine natural killer receptor protein 1A (NKRP1A), is a lectin-like receptor initially identified as a marker for NK (T) cells (22, 23) , but is also expressed on CD8 + T cells (24, 25) , Th17 cells (26, 27) , and innate lymphoid cells (ILC) (28) . In addition, Th17 cells expressing CD161 can convert to Th1 cells under pro-inflammatory conditions and thereby retain CD161 expression (29, 30) suggesting that CD161 may mark cells capable of T cell plasticity in inflammatory conditions. Despite the effector-like phenotype of CD161 + Treg, it is unknown how these cells relate to CD161
+ T effector cells. In this study, we aimed to define the transcriptional and protein signatures, and TCRβ repertoire of CD161 + Treg and CD161
+ conventional T cells (Tconv). CD161
+ Treg and CD161 + Tconv shared transcriptional and protein signatures and expressed high levels of cell surface proteins associated with gut homing. However, the TCRβ repertoire of these cells showed limited overlap. Intriguingly, at the site of inflammation in patients with autoimmune arthritis, the TCRβ repertoire of CD161 + and CD161 − Tconv, and CD161 + and CD161 − Treg showed a considerable amount of overlap suggesting that CD161 expression can be altered in autoimmune conditions.
MaTerials anD MeThODs human samples
Peripheral blood (PB) samples from healthy adult and child volunteers or patients with juvenile idiopathic arthritis (JIA) and synovial fluid (SF) samples from JIA patients were obtained with full written informed consent and age appropriate assent as approved by the London-Bloomsbury Research Ethics Committee (ref 95RU04) in accordance with the Declaration of Helsinki. JIA patients were diagnosed according to internationally agreed criteria (31) . PB and SF mononuclear cells (PBMC and SFMC) were prepared by density gradient centrifugation. Before processing, SF samples were treated with Hyaluronidase (10 U/ ml; Sigma-Aldrich) for 30 min at 37°C.
cell culture
Cells were cultured in RPMI1640-containing l-glutamine supplemented with penicillin (100 U/ml), streptomycin (100 µg/ml), and 10% FCS (all Thermo Fisher Scientific) at 37°C and 5% CO2. To assess cytokine production, cells were cultured with Phorbol Myristate Acetate (PMA) (50 ng/ml), Ionomycin (500 ng/ml) and Brefeldin A (5 µg/ml) (all Sigma-Aldrich) for 4 h, or recombinant human IL-12 (50 ng/ml; Pepro-Tech EC Ltd.), IL-18 (50 ng/ml; Bio-Techne) and Brefeldin A (5 µg/ ml; last 4 h only) for 24 h. Cell cycle profile was analyzed after 4 days of culture in presence of plate-bound αCD3 (1 µg/ml; clone UCHT1, R&D Systems) and αCD28 (5 µg/ml; clone CD28.2, BD Pharmingen) antibodies. For cultures with alltrans retinoic acid (ATRA; Sigma-Aldrich), cells were cultured in serum free medium (Thermo Fisher Scientific) in absence or presence of plate-bound αCD3 (1 µg/ml) and αCD28 (5 µg/ ml), and ATRA at concentrations indicated for 4 days (ATRA alone), or 48 h and then rested for 48 h (ATRA + TCR signal) before analysis.
Flow cytometry
Flow cytometry was performed by standard methods using directly conjugated monoclonal antibodies (Table S1 in Supplementary Material) against specific human cell surface or intracellular proteins. Dead cells were excluded by staining with a live/dead dye. Intracellular proteins were stained using Foxp3 staining kit (eBioscience). Cell cycle profile was analyzed using FxCycle Violet (Thermo Fisher Scientific). Data were acquired on LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software version 10.1 (Tree Star Inc.).
cell sorting
PBMC from adult healthy controls or JIA patients, or SFMC from JIA patients were enriched for CD4 + T cells using EasySep Human CD4
+ T Cell Enrichment kit (Stemcell Technologies) and stained for CD4, CD127, CD25, and CD161 using the monoclonal antibodies defined in Table S1 in Supplementary Material, before adding a live/dead dye. Cells were sorted on FACS Aria III (BD Biosciences) for the following live cell populations:
A small aliquot of each sorted cell populations was stained for Foxp3 to assess sort purity.
Treg suppression assay

CD161
+ and CD161 − Treg and total Tconv were sorted from JIA SF. To assess suppression of proliferation, sorted Tconv were labeled with CellTrace Violet (Thermo Fisher Scientific) according to manufacturer's instructions. Labeled Tconv were cultured at a constant number of 5 × 10 4 cells per well, either alone (1:0) or with sorted CD161 + or CD161 − Treg at a 1:1 and, where cell numbers permitted, 2:1 ratio. Cells were cultured on a 96 well V-bottom plate pre-coated with plate-bound αCD3 (1 µg/ml) and αCD28 (5 µg/ml) antibodies. Final cell concentration was kept at 1 × 10 6 cells per ml. Cells were cultured for 4 or 5 days at 37°C and 5% CO2 before analysis by flow cytometry. To determine suppression of proliferation, the % divided function in FlowJo version 7.6.5 (Tree Star Inc.) was used and % divided for Tconv alone was set at 0% suppression. rna extraction and rnaseq RNA was extracted from sorted populations using Picopure kit (Thermo Fisher Scientific), and the cDNA library was prepared using TruSeq RNA sample preparation kit (Illumina). Samples were run on HiSeq 2500 (Illumina), rapid run mode 50PE with average read depth of 30 million reads. After sequencing, reads were mapped to the human genome (human NCBI genome build 37.2) and read count data for each transcript were obtained using the scripts provided by the Dexseq package. FPKM values were created using the normalization tools included in the Deseq2 package followed by subsequent analysis using GeneSpring 13.0 (Agilent Technologies) to determine differentially expressed (DE) genes using P < 0.05 (determined using unpaired t-test without correction for multiple testing) and fold change ≥1.5.
One CD161
+ Treg sample was excluded from analysis, because of low cDNA yield. Transcriptome data have been deposited in GEO under accession number GSE86452. Principal component analysis (PCA) of the dataset was performed using FactoMineR (32) in RStudio (version 3.2.2). Heatmaps were generated using GENE-E. 1 Pathway analysis was performed using QIAGEN's Ingenuity ® Pathway Analysis (IPA ® , QIAGEN Redwood City 2 ).
TcrB sequencing and analysis
Genomic DNA (gDNA) was extracted as described (33) from purified CD161 + and CD161 − Tconv and Treg. 100-400 ng gDNA was processed by Adaptive Biotechnologies (Seattle, WA, USA) using the ImmunoSEQ human TCRB platform combining multiplex PCR with high throughput sequencing and a sophisticated bioinformatics pipeline for TCRB CDR3 analysis (34, 35) . Data were analyzed using ImmunoSEQ Analyser (version 3.0) using only productive rearrangements at nucleotide level. Figure 1D ). These data suggest that differences in cytokine production between CD161 + and CD161 − cells might not solely be attributed to differences in memory phenotype.
statistical analysis
Despite the pro-inflammatory phenotype typically associated with effector T cells, CD161
+ Treg from healthy controls also exhibited a classical Treg phenotype. CD161 + Treg expressed significantly higher levels of CTLA4, GITR, and PD1 compared to CD161
− Treg in blood of healthy adults ( Figure 1E ; Figures S2A-C in Supplementary Material). Within blood of healthy children, only CTLA4 protein expression was significantly higher within CD161
+ Treg compared to CD161 − Treg. We observed no significant difference in protein expression of TIGIT ( Figure 1E ; Figure S2D in Supplementary Material), a marker identifying a suppressive Treg population that also shares features with effector T cells (36, 37 (Tables  S4 and S5 in Supplementary Material, respectively) showed that similar pathways were altered in both signatures ( Figure 2D) . Among the over-represented pathways were the T helper differentiation pathway and pathways associated with cell migration, including epithelial adherens juction, actin cytoskeleton signaling, + Tconv (blue bars) and CD161 + Treg (red bars) signatures identified using ingenuity pathway analysis with −log P-value >2 (equals P-value <0.01). + and CD161 − Tconv from 2 healthy adult controls. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001. Many differentially expressed genes were part of the T helper differentiation pathway including those specifically associated with Th1 and Th17 cells. CD161 + Tconv showed significantly higher expression of TBX21 and IRF5 (Th1 transcription factors), and RORC and RORA (Th17 transcription factors) were significantly higher in both CD161
+ Tconv and CD161 + Treg compared to their CD161 − counterparts. AHR expression was only significantly higher in CD161
+ Tconv compared to CD161 − Tconv ( Figure 2E ; Figure S4A in Supplementary Material). Interestingly, GATA3 expression was also higher in CD161 + Tconv and CD161 + Treg, and BCL6 was higher in CD161 + Tconv, but not CD161 + Treg, + Tconv showed significantly higher expression of IFNG compared to CD161 − Tconv ( Figure 2E ; Figure S4B in Supplementary Material), but expression levels of other cytokine transcripts, including IL4, IL10, IL13, IL21, and IL22, showed no significant differences in expression between CD161 + and CD161 − populations (data not shown). Furthermore, expression of chemokine receptors associated with migration of Th cells, including CCR6 (Th17) (Figure 2E ; Figure S6A in Supplementary Material), CCR5, and CXCR3 (both Th1), was higher in CD161 + Tconv and CD161 + Treg (Figures 2E-G) . We and others have previously demonstrated high levels of CCR6, RORC, and T-bet in CD161 + T populations (14, 26, 29) . Here, we report an increase in percentage CCR5 + cells in both CD161
+ Tconv and CD161 + Treg ( Figure 2F ) and higher protein expression of CXCR3 ( Figure 2G) Tconv  Treg  CD161+ CD161-CCR5  CXCR6  CCR2  ITGA4  ITGA3  CCR6  CCR4  CXCR3  CXCR5  ICAM1  ITGAL  ITGAM  ITGB1  CCR7  ITGA6   CCR4  CCR6  CXCR6  CCR2  CCR5  CCR9  ITGA4 
cD161 + T cells have a Proliferative Phenotype
Several functional pathways that were over-represented in CD161 + Treg were associated with cell cycle progression (Table S5 in Supplementary Material). In vitro analysis of cell cycle profile showed a non-significant trend towards more CD161 + T cells in S and G2M phases compared to CD161 − T cells ( Figure 3A) . Consistent with this observation, the percentage of Ki67 + cells within CD161 + Tconv and CD161 + Treg was significantly higher compared to CD161 − cells within blood of healthy adults, but this trend did not reach statistical significance in the four healthy children analyzed ( Figure 3B) . Together, these data suggest that CD161 + T cells have a high proliferative turnover, which indicates that these cells may have recently encountered their cognate antigen.
The proliferative phenotype of CD161 + Treg could be confounded by the high proportion of memory cells within CD161 + Treg ( Figure 1C) (Figures 4A,B) . Analysis of CCR9 and integrin α4β7 showed significantly higher percentages of CCR9 + ( Figure 4C ) and integrin α4 + β7 + ( Figure 4D ) cells within CD161 + Tconv and CD161
+ Treg compared to CD161 − populations in blood from healthy adults. In healthy children (n = 4-8), percentage CCR9 (Figure 4D ). Retinoic acid (RA), the active form of vitamin A, plays an important role in T cell-mediated immune responses and is known to induce gut homing of lymphocytes (45) . Since both CCR9 and ITGA4 are direct targets of RA (46, 47), we hypothesized that CD161 + T cells express higher levels of CCR9 and integrin α4β7 because they have been exposed to a RA signal during T cell differentiation, whereas CD161 − T cells have not been previously exposed. To determine whether CD161 − T cells can upregulate CCR9 and integrin α4β7, PBMC from healthy adults were activated in presence of all-trans retinoic acid (ATRA), the predominant biological form of RA. + and CD161 − Treg at 1:0 (n = 5), 1:1 (n = 5), and 2:1 ratio (n = 4). Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001. Figure 4F ) (Figures 4E,F Figure S5C in Supplementary Material) or ATRA alone ( Figure 4G ). To exclude any potential effects of other cell populations within PBMC, sorted CD161 + and CD161 − Tconv from healthy adults were exposed to ATRA with or without TCR stimulation. We observed similar results for expression of CCR9 and integrin α4β7 when cells were exposed to ATRA + TCR ( Figure S5D We also analyzed expression of chemokine receptors and integrins, which mediate homing to other tissues within the RNAseq dataset. Indeed, both CD161 + Tconv and CD161 + Treg expressed significantly higher levels of CCR2, CCR4, CCR5, CCR6, and CXCR6 ( Figures 2E,F and 4A ; Figure S6A in Supplementary Material). Furthermore, CD161
+ Tconv expressed significantly lower levels of CCR7, but significantly higher levels of CXCR3 and CXCR5 (Figures 2E,G and 4A; Figure S6A in Supplementary Material). In addition, CD161 + Tconv expressed significantly higher levels of ITGA3, ITGA6, ITGAL, ITGAM, ITGB1, and ICAM, whereas CD161 + Treg only expressed significantly higher levels of ITGAM ( Figure S6B in Supplementary Material). Expression of CCR4, CCR5, CXCR3, CXCR6, and integrin α4β1 has previously been associated with T cell homing to specific tissues including lung, skin, liver, and heart (48, 49 + Treg indicating that these populations most likely do not originate from the same precursor cell (Figures 5A-C) . Clonality of CD161
+ Tconv, CD161 + Treg, and CD161 − Treg was similar to the median clonality (0.075) of the adult TCR repertoire in blood, whereas clonality for CD161 − Tconv was much lower. The Shannon entropy score (normalized measure of diversity of the rearrangements) was similar for all populations (Figure 5D ).
enrichment of cD161
+ T cells at the inflamed site, but cD161+ T cells from the inflamed site show lower expression of gut-homing Markers Given the pro-inflammatory phenotype of CD161 + T cells, we sought to address the relevance of these cells in inflammation. We analyzed the frequency of CD161 + Tconv and CD161 + Treg in childhood autoimmune arthritis, JIA, and found that CD161 + Tconv and CD161 + Treg were significantly enriched in JIA SF compared to JIA and HC PB (Figure 6A) . The cytokineproducing phenotype of CD161 + T cells was also maintained in JIA PB and SF ( Figures S7A,B in Supplementary Material) . Functionally, both CD161
+ and CD161 − Treg from JIA SF were able to suppress proliferation of Tconv cells in an in vitro suppression assay. There was no significant difference in suppressive capacity between the CD161 + and CD161 − Treg populations ( Figure 6B) .
Given the observed expression of CCR9 and α4β7 on CD161 Figures 7A,B) . The proportion of integrin α4 + β7 + cells in CD161 + Tconv and CD161
+ Treg compared to CD161 − populations was still significantly higher in JIA SF (Figures 7A,B) , although, the proportions of integrin α4 + β7 + cells within both CD161 + Tconv ( Figure 7A ) and CD161
+ Treg ( Figure 7B ) were also lower in JIA SF compared to JIA PB. To determine whether cells from SF can upregulate expression of CCR9 and integrin α4β7, SFMC from JIA patients were exposed to ATRA in presence or absence of a TCR signal. We observed no change in percentage CCR9
+ cells within CD161 + and CD161 − CD3 + CD4 + cells upon activation of SFMC in presence of ATRA plus a TCR signal, whereas percentage integrin α4 Figure 7C ). There was no significant change in percentage CD161 + CD3 + CD4 + cells during ATRA treatment ( Figure 7D ).
RA can be synthesized in response to inflammation (58) (59) (60) (61) , but the lower levels of CCR9 + and integrin α4 + β7 + cells in JIA SF suggest prior imprinting by RA in the gut or at peripheral sites rather than during synovial inflammation.
Overlap in Tcrβ repertoire between cD161
+ and cD161 − Tconv and Treg from the inflamed site
To determine whether CD161
+ and CD161 − Tconv and Treg from the site of inflammation in JIA patients also represent distinct cell populations as observed in blood, we analyzed their TCRβ repertoire. Interestingly, there was considerable overlap in TCRβ repertoire between both CD161
+ and CD161 − Tconv, and CD161
+ and CD161 − Treg from JIA SF. In addition, there was some degree of overlap (~20%) between CD161 + Tconv and CD161 + Treg from JIA SF (Figures 8A-C) . PB TCRβ repertoire analysis of CD161 + and CD161 − Tconv from one JIA patient showed very limited overlap (Figures 8B,C) . Furthermore, we observed limited overlap in TCRβ repertoire between CD161
+
Tconv or CD161
− Tconv between paired PB and SF ( Figure 8C ). However, it should be noted that the number of sequences obtained for CD161
+ and CD161 − Tconv from JIA PB was much lower compared to JIA SF. Cell populations from JIA SF had a higher clonality score compared to cell populations from JIA PB, whereas Shannon entropy scores were similar ( Figure 8D) . The overlap in TCRβ repertoire between CD161
+ and CD161 − Tconv and Treg from the site of inflammation contradicts the limited overlap observed in blood from controls and suggests that in an inflamed environment CD161 expression might be more labile.
DiscUssiOn
In this study, we identified a shared transcriptional signature between CD161
+ Tconv and CD161 + Treg from blood despite limited overlap in TCRβ repertoire. In addition, we reported that CD161 + T cells showed higher expression of tissue-homing receptors, including the gut-homing markers CCR9 and integrin α4β7; whereas expression of these markers was lower on CD161 
CD4
+ T cells at end of culture. Statistical significance: *P < 0.05, **P < 0.01, ***P < 0.001. 
CD161
+ T cells was reduced when cells were pre-treated with anti-CD161 mAb (63) (64) (65) . In addition, CD161 + CD4 + T cells have previously been detected in gut (26, 66, 67) , skin (26) , lung (68) , and synovial tissue (69) . These data indicate that CD161 + T cells might be more prone to migrate into tissues compared to CD161 − T cells. Our demonstration of high expression of tissuehoming receptors supports this concept.
Transcriptome and protein data showed higher expression of CCR9 and integrin α4β7, markers associated with gut homing (43, 44) , on CD161 + T cells from blood. In contrast, CD161 + T cells from the inflamed site contained fewer CCR9 + and integrin α4 + β7
+ cells compared to blood and exposure to RA failed to alter expression of CCR9, whereas there was a trend toward increased integrin α4β7 levels within CD161 + T cells. RA synthesis occurs in the gut under homeostatic conditions, but can also be induced at systemic sites in response to inflammation (58) (59) (60) (61) . Upregulation of RA synthesis at peripheral sites has been shown to induce expression of CCR9 and α4β7 on lymphocytes with subsequent gut homing (59, 61) . The increased expression of CCR9 and α4β7 on CD161 + T cells from blood as well as the ability of these cells to respond to RA to a greater degree than CD161 − T cells suggests that these cells may have received a RA signal during T cell priming, either in the gut or the periphery, which resulted in gut homing. The enrichment of CD161 + T cells in SF suggests that these cells might then migrate towards the synovial joint where they contribute to disease pathogenesis. We believe that these findings highlight a potential gut-joint axis. Future studies to demonstrate whether CD161 + T cells are trafficking from the gut to the joint, for example by analyzing overlap in TCRβ repertoire from CD161 + T cells from gut tissue and SF of the same patient, would be of interest.
In order to retain CD161 + T cells in the joint, our data suggest that cells lose their gut-homing phenotype and their ability to respond to RA. Possible mechanisms include downregulation caused by signals present in SF or following interaction with ligands in vivo. Alternatively, a high antigen dose has been reported to limit ATRA-induced CCR9 expression on activated CD8 + cells (70) . It is very likely that cells are exposed to high antigen levels at the inflamed site and this could possibly overcome the RA-induced expression of gut-homing markers. In addition, high expression of integrin β1 was found to prevent binding of integrin α4 and β7 (47) . High levels of integrin α4β1 have been observed on SF T cells in rheumatoid arthritis (71) , which could explain the low expression of integrin α4β7 in JIA SF. Interestingly, CD161
+ and CD161 − Tconv and Treg are highly enriched for integrin α4 + β1 + cells in the synovial joint (C.L.D. unpublished data).
The maintained cytokine-producing phenotype of both CD161 + Tconv and CD161 + Treg in JIA SF is in accordance with previously published studies reporting that CD161 + T cells from JIA (29, 30, 72) and rheumatoid arthritis (69) patients produce multiple pro-inflammatory cytokines. In addition, CD161 + and CD161 − cell populations from the inflamed site. In addition, CD161
+ Tconv and CD161 + Treg showed overlap (~20%) in TCRβ repertoire suggesting that a small proportion of CD161 + Treg might convert to CD161 + Tconv or the other way around within the inflammatory environment. In a previous study, we observed limited overlap (<10%) between TCR clones of Tconv and Treg from JIA SF (33) . However, in this study, Tconv and Treg were not divided into CD161
+ and CD161 − cells, potentially explaining the different results. The shared TCRβ repertoire between CD161 + and CD161 − Tconv, and CD161 + and CD161 − Treg suggests that the inflamed site might create an environment that alters CD161 expression causing a switch between nonand pro-inflammatory phenotypes and thereby contributes to disease pathogenesis.
Potential limitations of this study are that TCRβ repertoire was only analyzed in a limited number of samples, which was partially due to the limited availability of paired PB and SF samples from JIA patients with sufficient cell numbers for cell sorting of all four populations. Therefore, the number of sequences obtained for CD161
+ and CD161 − Tconv from JIA PB was much lower compared to JIA SF, and the TCRβ repertoire of CD161 + and CD161 − Treg from JIA PB was not analyzed due the small volumes of blood obtained from JIA patients and thus insufficient number of cells for sorting.
Data reported here suggests that trafficking of CD161 + T cells through the gut might be a necessary process in order to shape the course of immune responses in for example the synovial joint. The functional relevance of this process remains elusive, but the gut-joint axis could provide a novel therapeutic target as for example maybe a simple change in diet might help restore the balance in the gut and impact upon or even resolve symptoms. Analysis of TCRβ repertoire suggested that CD161 expression is regulated differently in health and disease. Therefore, it will be important to define mechanisms controlling CD161 expression.
In addition, the indication that CD161 expression might be labile at the inflamed site suggests that the pro-inflammatory phenotype may be switched "on" or "off, " possibly due to factors present the synovial environment. Future studies should focus on functional relevance of CD161 and the labile CD161 expression in inflammatory conditions as this could yield great therapeutic potential. aUThOr cOnTriBUTiOns CD, CB, RO, and LW were responsible for experimental design, interpretation of the data, and revising the manuscript for intellectual content. CD acquired and analyzed the data and drafted the manuscript. All authors approved the final version of the submitted manuscript.
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